ORIGINAL RESEARCH article
Front. Immunol.
Sec. Systems Immunology
This article is part of the Research TopicDevelopment of Diagnostic and Therapeutic Biomarkers for Tumors and Inflammation Based on Multi-omics Approaches Including Transcriptomics, Proteomics, and MetabolomicsView all 13 articles
Identification of key genes related to metabolic cell death in hepatic ischemia-reperfusion injury from transcriptome data and mechanism research using single-cell data
Provisionally accepted- 1Tianjin First Central Hospital, Tianjin, China
- 2Peking University Third Hospital, Beijing, China
- 3Fujian Medical University Union Hospital, Fuzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Ferroptosis and cuproptosis are closely associated with hepatic ischemia-reperfusion injury (HIRI). However, the significance of metabolic cell death-related genes (MRGs) in HIRI still awaits exploration. This study examined the molecular mechanisms through which key genes contribute to metabolic cell death in HIRI. Methods: GSE12720, GSE14951, and GSE171539 datasets and 478 MRGs were included. First, candidate genes were screened through differential expression analysis combined with MRGs. Then, key genes were identified by using machine learning algorithms combined with expression verification. Subsequently, the analyses included constructing and evaluating nomograms, conducting functional enrichment studies, characterizing immune infiltration, building regulatory networks, performing drug prediction, and executing molecular docking. Importantly, single-cell analysis was conducted to identify key cell populations Finally, expression levels of key genes in animal samples were determined by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results: The analysis identified ATF3, TNFAIP3, IL1B, and KDM6B as central genes. The nomogram indicated that these four key genes could well predict the occurrence of HIRI. Functional enrichment analysis revealed significant associations of ATF3, TNFAIP3, and KDM6B with olfactory transduction pathways. The key genes were positively linked to most differential immune cells, and ATF3 had the most significant positive relation to activated CD4 This is a provisional file, not the final typeset article T cells. The binding energies of molecular docking between key genes and corresponding drugs were all less than -5 kcal/mol. Mononuclear phagocytes were identified as key cells, and the expressions of ATF3, IL1B, and KDM6B had dynamic and non-linear change characteristics during the differentiation of mononuclear phagocytes. RT-qPCR results demonstrated that ATF3, TNFAIP3, IL1B, and KDM6B were up-regulated in HIRI samples, consistent with the results in the GSE12720 and GSE14951 datasets. Conclusion: In HIRI pathogenesis research, ATF3, TNFAIP3, IL1B and KDM6B were validated as core regulators of metabolic cell death, offering critical targets for mechanistic investigation.
Keywords: Drug prediction, Hepatic ischemia-reperfusion injury, key genes, Metabolic Cell Death, single-cell RNA sequencing
Received: 31 Aug 2025; Accepted: 02 Dec 2025.
Copyright: © 2025 Yu, Cao, Cao, Weng and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xianfeng Weng
Weituan Xu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
